ExpansionJul 6, 2026, 09:01 AM
NewGenIvf UAE Cell Sorting Entity Valued at $19M
AI Summary
NewGenIvf Group Ltd announced an independent Big Four valuation of approximately $19 million for its planned UAE-based cell sorting and cytometry leasing business. This valuation highlights the significant growth potential in the high-infertility GCC market, projected to reach $444 million by 2030. The company also appointed industry veteran Nadeem Malik as Senior Strategic Advisor to spearhead the UAE/GCC expansion, leveraging his expertise in IVF and cell sorting operations.
Key Highlights
- NewGenIvf's planned UAE cell sorting entity received a midpoint equity valuation of approximately $19 million.
- This valuation builds on a prior Big Four valuation of its advanced cytometry IP at $17.9 million (Oct 2025).
- The UAE IVF market is projected to grow from ~$270 million in 2024 to ~$444 million by 2030 (CAGR ~8.5%).
- Nadeem Malik, former CEO of Genetics and IVF Institute, appointed Senior Strategic Advisor to lead UAE/GCC expansion.
- NewGenIvf plans to lease advanced cytometry devices and operate a centralized, high-throughput sorting hub in the UAE.
Price Impact
More from NIVF